![]() | ||||
|
|
|
Choosing ASCTAt St. Luke's, choosing autologous stem cell transplant as a treatment for cancer involves the patient, the patient's loved ones, and the medical team involved in the treatment. ASCT has been used in the treatment of Hodgkin's lymphoma, non-Hodgkin's lymphoma, acute leukemia, multiple myeloma, ovarian cancer, testicular cancer, breast cancer and other solid tumors. ASCT team members evaluate a number of factors, including the type of cancer, the stage of the disease, whether the disease is responsive to chemotherapy, and the patient's overall medical condition. Numerous tests, often done on an outpatient basis, are performed to determine whether ASCT is an option. Autologous stem cell transplant requires intensive treatment and a hospital stay, both of which can be physically and emotionally stressful. Once the patient is determined to be eligible for ASCT, the patient needs to make an informed decision -- with the support of St. Luke's ASCT team -- about whether to proceed. [ previous page ]
|
||
|
||||